Literature DB >> 9252520

Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake.

J V Castell1, G Friedrich, C S Kuhn, G E Poppe.   

Abstract

The human adult intestinal epithelium has traditionally been described as nonpermeable to proteins. However, indirect evidence suggests that reduced absorption of undegraded proteins might take place under physiological conditions. Using bromelain (an enzyme obtained from pineapple stems) as a model protein, we studied the extent of this mucosal permeation in 19 healthy men. The protein was detected in plasma by immunoassay and by its proteolytic activity after oral administration. The estimated plasma half-life was 6-9 h. After oral multidosing (3 g/day), plasma concentration reached as much as 5,000 pg/ml by 48 h. From the plasma concentration curve, it could be estimated that an average of 10.8 micrograms of bromelain was present in plasma in the 3- to 51-h period. The presence of undegraded bromelain in plasma was shown unequivocally by immunoprecipitation of plasma samples with antibromelain antibodies, followed by gel electrophoresis and immunodetection. Moreover, the enzyme retained its biological activity, at least in part. Circulating bromelain was found associated with alpha 2-macroglobulin and alpha 1-antichymotrypain. The results of this work confirm the existence of a small but significant intestinal transport of undegraded proteins in healthy men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252520     DOI: 10.1152/ajpgi.1997.273.1.G139

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin: review on absorption of serine and cysteine proteases.

Authors:  Gerhard Lorkowski
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-02-28

2.  Intestinal Absorption of Fibrinolytic and Proteolytic Lumbrokinase Extracted from Earthworm, Eisenia andrei.

Authors:  Xiang Mei Yan; Chung-Hyo Kim; Chul Kyu Lee; Jang Sik Shin; Il Hwan Cho; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

3.  Dose-dependent induction of IL-6 by plant-derived proteases in vitro.

Authors:  B Rose; C Herder; H Löffler; G Meierhoff; N C Schloot; M Walz; S Martin
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

4.  Transport of proteolytic enzymes across Caco-2 cell monolayers.

Authors:  U Bock; C Kolac; G Borchard; K Koch; R Fuchs; P Streichhan; C M Lehr
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

5.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

6.  Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease.

Authors:  Eric R Secor; William F Carson; Michelle M Cloutier; Linda A Guernsey; Craig M Schramm; Carol A Wu; Roger S Thrall
Journal:  Cell Immunol       Date:  2005-12-06       Impact factor: 4.868

7.  Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study.

Authors:  Krishna Pillai; Javed Akhter; David L Morris
Journal:  Pleura Peritoneum       Date:  2017-06-06

8.  Inability to detect significant absorption of immunoreactive soya protein in healthy adults may be relevant to its weak allergenicity.

Authors:  Cecilia M Lund; Christina G Dirks; Mona H Pedersen; Bettina M Jensen; Lars K Poulsen
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

9.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10

10.  LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr.

Authors:  Eric R Secor; Steven M Szczepanek; Anurag Singh; Linda Guernsey; Prabitha Natarajan; Karim Rezaul; David K Han; Roger S Thrall; Lawrence K Silbart
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.